ALRN-6924 vs Huwentoxin-IV

Head-to-head comparison of ALRN-6924 (ALRN-6924 dual MDM2/MDMX stapled p53 mimetic peptide) and Huwentoxin-IV (Huwentoxin-IV from Selenocosmia huwena venom) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyALRN-6924Huwentoxin-IV
CategoryExperimentalExperimental
Full NameALRN-6924 dual MDM2/MDMX stapled p53 mimetic peptideHuwentoxin-IV from Selenocosmia huwena venom
Molecular WeightN/A4,000 Da
Half-LifeHours to days depending on formulationMinutes to hours
Amino AcidsN/A35
Typical DoseVaries by clinical protocol0.01-1 nmol intrathecal|1-100 nM in vitro|single-dose rodent studies
RouteIntravenous/SubcutaneousIntrathecal
Purity≥98%≥98%
Studies Count40110
Research StatusClinicalPre-clinical

ALRN-6924 Benefits

  • p53 reactivation
  • dual MDM2/MDMX inhibition
  • protease resistance
  • tumor cell apoptosis

Huwentoxin-IV Benefits

  • Nav1.7 selectivity
  • pain-channel validation
  • action-potential research
  • analgesic lead optimization

ALRN-6924 Dosing

Clinical trial protocol dosing|Intermittent administration|Research-only escalation

Huwentoxin-IV Dosing

In vitro Nav1.7 electrophysiology|Intrathecal rodent analgesia studies|Single-bolus channel selectivity assays

ALRN-6924 Side Effects

  • nausea
  • fatigue
  • myelosuppression

Huwentoxin-IV Side Effects

  • Neurological impairment at high exposure
  • off-target sodium-channel effects
  • injection-site irritation

Research Overview

ALRN-6924

ALRN-6924 is one of the best-known stapled peptide therapeutics and has advanced into human oncology studies. Literature shows that hydrocarbon stapling can improve target affinity, serum stability, and cellular activity for this p53-mimetic scaffold.

Huwentoxin-IV

Studies show huwentoxin-IV can inhibit sodium-channel currents with notable selectivity, making it useful for dissecting pain-sensing neuron excitability. It is one of the better known spider-venom templates for Nav1.7-targeted drug discovery.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

ALRN-6924 stacks with:

venetoclaxcisplatindoxorubicin

Huwentoxin-IV stacks with:

pregabalinlidocainemorphine
stapled-peptidep53mdm2mdmxoncologyspider-venomsodium-channelnav1.7pain-research